Kerecis Completes Interim Financing
May 24, 2011 14:28 ET
|
Kerecis
REYKJAVIK, ICELAND and ISAFJORDUR, ICELAND--(Marketwire - May 24, 2011) - Kerecis Limited, the emerging tissue-regeneration company, has secured US$ 1 million in interim financing.The US$ 1 million...
Kerecis Limited Receives ISO 13485:2003 Quality Management System Certification
March 25, 2011 11:00 ET
|
Kerecis
REYKJAVIK, ICELAND and ISAFJORDUR, ICELAND--(Marketwire - March 25, 2011) - Kerecis Limited, the emerging tissue-regeneration company, has received the International Organization for Standardization...
Kerecis to Present at Seed Forums in London and New York
November 03, 2010 16:39 ET
|
Kerecis
REYKJAVIK, ICELAND and ISAFJORDUR, ICELAND--(Marketwire - November 3, 2010) - Kerecis ehf, the emerging tissue-regeneration company, today announced that its Chairman G. Fertram Sigurjonsson...
Glycotex, Inc. Obtains Active IND From US Food and Drug Administration for GLYC-101 Wound Healing Compound
January 07, 2008 18:58 ET
|
Glycotex, Inc., Novogen Limited
ROCKVILLE, MD--(Marketwire - January 7, 2008) - Glycotex, Inc. announced today that it had
obtained an active Investigational New Drug Application (IND) from the US
Food and Drug Administration (FDA)...